1. Carelli V. et al "A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16" Hum Mol Genet. 2011 May 15;20(10):1893-905
2. Sarikaya E. et al "Hypergonadotropic hypogonadism, progressive early-onset spinocerebellar ataxia, and late-onset sensorineural hearing loss: case report and literature review" Balkan J Med Genet. 2011 Dec;14(2):77-88
3. Marshall JD. et al "Alström syndrome: genetics and clinical overview" Curr Genomics. 2011 May;12(3):225-35
4. Collin GB. et al "Homozygosity mapping at Alström syndrome to chromosome 2p" Hum Mol Genet. 1997 Feb;6(2):213-9
5. Stapleton P. et al "Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9" Nat Genet. 1993 Apr;3(4):292-8
6. Kleinjan DA. et al "Characterization of a novel gene adjacent to PAX6, revealing synteny conservation with functional significance" Mamm Genome 2002 Feb;13(2)102-107
7. Jordan T. et al "The human PAX6 gene is mutated in two patients with aniridia" Nat Genet 1992 Aug;1(5):328-32
8. Mukkamala K. et al "Choroideremia in a woman with ectodermal dysplasia and complex translocations involving chromosomes X, 1, and 3" Ophthalmic Genet. 2010 Dec;31(4):178-82
9. Mücke J. et al "MIDAS syndrome respectively MLS syndrome: a separate entity rather than a particular lyonization pattern of the gene causing Goltz syndrome" Am J Med Genet. 1995 May 22;57(1):117-8
10. Faivre L. et al "In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome" J Med Genet. 2003 Jan;40(1):34-6
The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.